Trials / Unknown
UnknownNCT05344495
Efficacy of Median Nerve Hydrodissection by Hyalase Versus Midazolam in the Treatment of Carpal Tunnel Syndrome:
Efficacy of Median Nerve Hydrodissection by Hyalase Versus Midazolam in the Treatment of Carpal Tunnel Syndrome: A Randomized, Clinical Trial.
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Minia University · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Comparing efficacy of hyalase and midazolam in median nerve entrapement neuropathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hyalase group | bupivacaine 15 mg 0.5% plus 2 mL normal saline containing 300 international units (IU) hyaluronidase. |
| DRUG | midazolam group | 2 mg midazolam dissolved in 2 ml sterile saline plus 15 mg bupivacaine 0.5% |
Timeline
- Start date
- 2022-01-10
- Primary completion
- 2022-07-20
- Completion
- 2022-08-01
- First posted
- 2022-04-25
- Last updated
- 2022-06-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05344495. Inclusion in this directory is not an endorsement.